Table 2.
Post-transfer outcomes
| Outcome | Before transfer clinic | Attended transfer clinic | p value |
|---|---|---|---|
| Non-adherent behavior (%) | 62.5 | 18.8 | 0.03 |
| Self-reported non-adherence (%) | 43.8 | 12.5 | 0.05 |
| Undetectable CnI levels (%) | 18.8 | 12.5 | 1.00 |
| Non-attendance at clinic (%) | 62.5 | 25 | 0.07 |
| Non-attendance for blood tests (%) | 56.3 | 25 | 0.14 |
| Median change in creatinine in the first year, μmol/l (Q25—Q75) | 11.5 (0 to 16) | −3.5 (−9 to 11) | 0.03 |
| Median change in creatinine in the second year, μmol/l (Q25—Q75) | 19.8 (−5 to 12) | 11.6 (−4 to 28) | 0.63 |
| eGFR 1 year post-transfer, ml/min/1.73 m2 (mean ± SD) | 93.3 ± 31.9 | 84.2 ± 25.5 | 0.98 |
| eGFR 2 years post-transfer, ml/min/1.73 m2 (mean ± SD) | 81.1 ± 28.7 | 77.9 ± 24.8 | 0.81 |
| Change in eGFR 1 year post-transfer, ml/min/1.73 m2 (mean ± SD) | −12.2 ± 14.9 | −0.9 ± 13.2 | 0.045 |
| Change in eGFR 2 years post-transfer, ml/min/1.73 m2 (mean ± SD) | −18.4 ± 23.1 | −13.4 ± 24.6 | 0.35 |
CnI calcineurin inhibitor, eGFR estimated glomerular filtration rate